acute gastroenteritis. Noninfective gastroenteritis and colitis, unspecified
Conditions
Interventions
Intervention 1: Dimenhydrinate 4 doses (1mg/kg dose max 200 mg/dose). Intervention 2: placebo doses (1 mg / kg / dose to 50 mg / dose) during 6 days per week.
Treatment - Drugs
Placebo
Dimenhydrinate 4 doses (1mg/kg dose max 200 mg/dose)
placebo doses (1 mg / kg / dose to 50 mg / dose) during 6 days per week
Sponsors
Vice chancellor for research, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Diagnosis of acute gastroenteritis by Specialist Physicians, At least 5 episodes of vomiting in 12 Hours; Aged between 1 to 12 years. Exclusion criteria: Chronic medical conditions of pre-existing such as gastrointestinal disease; malignancy; metabolic; cardiac; endocrine and metabolism, immune or nervous disorder. Secondary diagnosis of suspected from abdominal surgery or Or gynecologic conditions, urinary tract infections; migraine or meningitis. The use of antiemetic therapy in the 48 hours before the visit to the emergency. Use of other drugs such as acetaminophen or ibuprofen in the last 48 hours. History of allergies or adverse reactions to dimenhydrinate. Severe loss of water and requires urgent treatment with intravenous fluids. Hematemesis or hematochezia.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of vomiting episodes. Timepoint: Within 24 hours after using the first dose of prescription medication. Method of measurement: visit. | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of episodes of diarrhea. Timepoint: Within 24 hours after using the first dose of prescription medication. Method of measurement: visit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReza Akramipour
Kermanshah university of medical sciences
Outcome results
None listed